Table 2 Clinical characteristics according to CKD273 risk threshold
From: Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria
Parameter | CKD273 > 0.343 (n = 69) | CKD273 < 0.343 (n = 86) | p value |
|---|---|---|---|
Age (years) | 62 (32–71) | 61 (29–71) | 0.173 |
Diabetes duration (years) | 13 (1–35) | 12.5 (1–36) | 0.455 |
Gender (m/f) | 59/10 | 59/27 | *0.014 |
Smokers (year/n) | 24/45 | 18/68 | 0.054 |
BMI (kg/m2) | 31 (23–56) | 32 (22–48) | 0.324 |
SBP (mmHg) | 130 ± 17 | 129 ± 16 | 0.725 |
DBP (mmHg) | 74 ± 11 | 75 ± 12 | 0.574 |
HbA1c [%] (mmol/mol) | [7.5] 58 (42–110) | [7.6] 60 (39–123) | 0.267 |
Cholesterol (mmol/L) | 3.9 (2.3–6.7) | 3.8 (2–6.6) | 0.893 |
HDL (mmol/L) | 1.1 (0.4–2.2) | 1.1 (0.7–3.1) | 0.066 |
LDL (mmol/L) | 1.8 (0.5–4.4) | 1.7 (0.4–4.2) | 0.342 |
Creat (µmol/L) | 80 ± 18 | 75 ± 17 | *0.049 |
eGFR (mL/min/1.73 m2) | 86 ± 18 | 90 ± 15 | 0.143 |
UAER (mg/24 h) | 148 [70;385] | 55 [29;99] | *< 0.001 |
CKD273 | 0.546 (0.369–1.231) | 0.041 (− 1.078 to 0.347) | *< 0.001 |
CAD238 | − 0.463 ± 0.202 | − 0.586 ± 0.281 | *0.002 |
NT-proBNP (ng/L) | 52 (5–550) | 42 (5–576) | 0.615 |
CAC score | 676 ± 961 | 363 ± 547 | 0.018 |